AIDS: The Real Cause
This ground-breaking new book by Thomas A. Patterson provides the first comprehensive, scientific explanation of what really causes AIDS. It includes the results of more than 30 years of AIDS research and for the first time combines key findings of both proponents and critics of the standard HIV-AIDS explanation.
But Patterson goes one step further and adds the crucial, missing piece of the puzzle: a disease known as "The Great Imitator" to historians of medicine, as it has been misleading doctors repeatedly over the centuries by causing symptoms that imitate other illnesses. A disease that is caused by a microbe known to clinicians as the "stealth pathogen," because it subverts the immune system, evades detection by many standard testing procedures, survives treatment by most standard antibiotics, and may strike unexpectedly even years or decades after infection. A disease known as: syphilis.
By connecting the dots, a bigger picture emerges: it turns out that syphilis explains all aspects of AIDS conclusively, including modes of transmission, immunological characteristics, clinical symptoms, epidemiology both in developed and developing countries, and historical timing of the AIDS epidemic.
Historical documents reveal that a small group of pioneering researchers and doctors suspected chronic syphilis as the true cause of AIDS from the very beginning. At the time, they couldn't prove their case, hence they were ignored and soon forgotten - almost. Yet modern research shows that they may have been right all along.
Based on these insights, Patterson proposes a radically new and yet simple medical treatment scheme that may finally put an end to the 30-year epidemic of AIDS.
A real game changer.
130 scientific references. 20 illustrations and high-resolution micrographs.

How are we to appreciate and comprehend what it has been like to live with HIV and AIDS-related illness over the past three decades or more? When the AIDS pandemic began in the early 1980s, scientific knowledge and medical treatment had a limiting effect on quality of life and life expectancy for people living with HIV and AIDS-related illness. During this era the very idea of AIDS signified fear, panic, stigma, prejudice, acute chronic illness and the real threat of imminent death both within and outside of a UK context. As the global expansion of HIV scientific knowledge continues to develop, we observe a dramatic change in how the medical community defines HIV as a disease. The term AIDS has been largely discarded in the West and we resist the 'death sentence' scenario; instead we approach HIV as a chronic illness condition. With effective HIV combination therapies now available to those who can afford and access them, the successful management of HIV is perceived as within our reach. This story-of-stories brings together twenty eight long-term survivors all of whom were diagnosed between 1981 and 1994 prior to the advancement of HIV medicine; in some cases even before medical health checks for HIV, such as the CD4 count and viral load test were available. It is a passionate story-of-stories allowing the reader to become intimate with each story-teller who shared their personal experiences of living long-term with HIV and AIDS within a UK context: this is their gift We unearth how our story-tellers negotiated and managed everyday life living with this unpredictable illness condition based on in-depth interviews conducted during 2002. These poignant personal stories historically reflect upon long-term experiences of women and men living alongside HIV and AIDS-related illness; they show us how real people made sense of their lives and continued to 'live out' everyday life in the UK. It is a thorough and passionate portrayal of personal experiences revealed by the spirited women and men who took time out of their own lives to offer a valuable contribution to further public understanding of this stigmatised disease. By offering insights into different personal experiences of those who have lived long-term with an HIV-positive diagnosis, readers can appreciate and recognise the many ways of being HIV-positive. Chapter one explores how concepts such as health, illness and identity can be defined and how shared meanings differ between people who use these concepts on a daily basis. It also furnishes the reader with a brief history of HIV and AIDS to set the backdrop for how we should understand the potential dilemmas of living with a HIV-positive diagnosis during earlier more ignorant times. Chapter two reveals how story-tellers learned of their HIV-positive diagnosis. Chapter three examines the early years of living with HIV and explains how our story-tellers managed uncertainty. Chapter four discloses how sickness and health was negotiated and experienced before HIV medicine became more effective. In chapter five our story-tellers speak of how intimate and sexual relationships are experienced in the context of HIV. Chapters six and seven critically expose how long-term survivors experienced and negotiated complex and highly toxic combination therapies for the treatment of HIV in conjunction with relationships with the medical profession in earlier times. Chapter eight uncovers how networks of social support were negotiated and experienced over time. Following this, we reveal in chapter nine the positive and negative elements of living long-term with HIV or AIDS diagnoses. The final chapter delves into my own experiences as the researcher for the initial HIV study. The book offers an extensive glossary of medical terms at the back to assist readers in medical terms and words associated with HIV and AIDS.

The Health Resources and Services Administration (HRSA) of the United States Department of Health and Human Services has as its mission the improvement of access to health care and services for underserved and vulnerable populations. HRSA accomplishes this mission by partnering with community-based organizations in the delivery of health and social services, with academic health centers in the education of health professionals, and with State and local health departments in the areas of prevention, public health promotion and health care delivery. Improved quality of care and quality of life are the goals of the programs and initiatives of HRSA. To that end HRSA's HIV/AIDS Bureau has embarked on the publication of A Clinical Guide to Supportive and Palliative Care for HIV/AIDS. Through the work of visionaries in the fields of HIV/AIDS and palliative care, we conclude that excellent HIV care can be provided by integrating the principles and framework of palliative care into the delivery of care and services to people living with HIV/AIDS, throughout the continuum of illness. This integration of services holds the promise of patient and family-centered care that is proactive in addressing the multitude of issues with which patients are challenged. With this volume we seek to expand the definition of palliative care and to realize palliative care's full potential to improve the quality of care and the quality of life of those living with HIV/AIDS. The HIV/AIDS Bureau, through its Working Group on Palliative Care in HIV, has set forth the following working definition: Palliative care is patient- and family-centered care. It optimizes quality of life by active anticipation, prevention, and treatment of suffering. It emphasizes use of an interdisciplinary team approach throughout the continuum of illness, placing critical importance on the building of respectful and trusting relationships. Palliative care addresses physical, intellectual, emotional, social, and spiritual needs. It facilitates patient autonomy, access to information, and choice. Palliative care is complementary care, not alternative care, and therefore should not be provided only when disease-directed therapy fails or is unavailable. It is a mistake to adopt a palliative perspective and approach only at the last stages of illness. One need only reflect on the pain associated with receiving a first HIV diagnosis or upon the psychological and spiritual suffering that are the substrates of substance abuse and other behaviors exposing individuals to HIV, to realize the importance of using palliative care principles at all points along the course of this illness. Providers should focus their attention on comfort, relief of suffering, and quality of life throughout the course of HIV disease. The central role of medication adherence is not to be underestimated in stabilizing the course of disease, but other factors can be equally important in optimizing clinical outcomes. These factors include a wide range of hard-to-control socioeconomic as well as personal characteristics: an understanding of the disease process; empowerment in relation to personal health; a safe place to live; freedom from pain and distressing symptoms; adequate nutrition; treatment for substance abuse, depression and other mental illness; hope; adequate help of friends, family and other caregivers, especially when functional status is diminished and disease progression is ongoing. These challenges can be met successfully by using a palliative care framework to approach the patient, providers, caregivers, family, loved ones, and the health care system. This manual is organized to address the many aspects of palliative care that are key in caring for the person living with HIV and AIDS. A wealth of expertise and experience in the areas of HIV and palliative care has provided a unique document that expands the realms of both disciplines.

This book explains what HIV/AIDS is and how to take good care of yourself in order to rebuild your immune system, to prevent opportunist infections and to stay healthy despite your status. As you know, HIV is just a chronic disease and it may be very well controlled like other chronic diseases are.

"In this original and interdisciplinary book, Chase illuminates the unequal treatment faced by the Puerto Rican women she studied and creates compassion for the hardships they faced." -Michele Tracey Berger, author of The Intersectional Approach Surviving HIV/AIDS in the Inner City explores the survival strategies of poor, HIV-positive Puerto Rican women by asking four key questions: Given their limited resources, how did they manage an illness as serious as HIV/AIDS? Did they look for alternatives to conventional medical treatment? Did the challenges they faced deprive them of self-determination, or could they help themselves and each other? What can we learn from these resourceful women? Based on her work with minority women living in Newark, New Jersey, Sabrina Marie Chase illuminates the hidden traps and land mines burdening our urban health care system. For the women she studied, alliances with doctors, nurses, and social workers could literally mean the difference between life and death. By applying the theories of sociologist Pierre Bourdieu to the day-to-day experiences of HIV-positive Latinas, Chase explains why some struggled and even died while others flourished and occasionally thrived under difficult conditions. These gripping, true-life stories reveal the strategies utilized by the chronically ill among us who depend on the health care "safety net." Through her exploration of life and death among Newark's resourceful women, Chase provides the groundwork for transforming our ailing urban health care system. SABRINA MARIE CHASE is a medical anthropologist specializing in family medicine and racial and ethnic health care disparities. She is a health care researcher at the Robert Wood Johnson Medical School. A volume in the Studies in Medical Anthropology series, edited by Mac Marshall

Directs the reader to the authoritative guidance established in AR 600-110, Identification, Surveillance, and Administration of Personnel Infected with Human Immunodeficiency Virus (HIV), pertaining to human immunodeficiency virus (HIV), pertaining to human immunodeficiency virus (HIV) testing prior to entry on active duty or active for training.

Investing in Communities Achieves Results fills an important gap in the global knowledge on community level results and resources related to HIV and AIDS. While communities, in spite of their limited resources, have played a key role in the HIV/AIDS response, their contributions and innovative approaches to prevention, treatment, care, and support have not always been the focus of systematic and rigorous evaluations. To address this deficit, a series of studies-including evaluations in Burkina Faso, India, Kenya, Lesotho, Nigeria, Senegal, South Africa, and Zimbabwe-were undertaken over a three-year period (early 2009 to early 2012), helping to build a robust pool of evidence on the effects of community-based activities and programmes. A unique feature of this multicountry evaluation was the collaboration between two international organisations (the World Bank and the United Kingdom's Department for International Development) and a major civil society network (the U.K. Consortium on AIDS and International Development). Other attributes that contributed to the successful outcome were the sustained consultation process with civil society and stakeholders at the local, national, and global levels, and the collaboration among high-calibre, multi-disciplinary researcher teams. The book's findings are promising. At varying levels, depending on the country context, the HIV response in communities was shown to improve knowledge and behaviour and increase the use of health services- and even decrease HIV incidence. Evidence on social transformation was more mixed, with community groups found to be effective only in some settings. Each study in the evaluation provides a partial view of how communities shape the local response; however, taken together they constitute a significant pool of rigorous evidence on the contributions of communities, community groups, and civil society to the national and global HIV and AIDS response. The studies suggest that communities have produced significant results at the local level, which contribute to outcomes at the national level.

HIV/AIDS remains a major global health problem, despite the progress made in its prevention and treatment. Addressing this problem is not only a matter of more and better drugs, they need to be widely accessible and be affordable to the poor. This book makes, with a much welcomed interdisciplinary approach, an excellent contribution to understanding how the intellectual property regime can influence health policies and the lives of millions of people affected by the disease. The analysis provided by the various authors that contributed to this book will be of relevance not only to those working in the area of HIV/AIDS, but to those more broadly interested in public health governance and the role of intellectual property rights.' - Carlos Correa, University of Buenos Aires, Argentina'This is an important, innovative and, at times, controversial collection. Inter-disciplinary in approach, this collection will have appeal to those concerned with the global injustice in the context of HIV/AIDS. Investigating the legal, political and economic determinants of access to essential medicines, this is thought provoking collection which will resonate with many in both the academic and public policy community.' - Bryan Mercurio, The Chinese University of Hong Kong This important book brings together leading scholars from multiple disciplines, including intellectual property, human rights, public health, and development studies, as well as activists to critically reflect on the global health governance regime. The Global Governance of HIV/AIDS explores the implications of high international intellectual property standards for access to essential medicines in developing countries. With a focus on HIV/AIDS governance, the volume provides a timely analysis of the international legal and political landscape, the relationship between human rights and intellectual property, and emerging issues in global health policy. It concludes with concrete strategies on how to improve access to HIV/AIDS medicines. This interdisciplinary, global, and up-to-date book will strongly appeal to academics in law, international relations, health policy and public policy, as well as students, policymakers and activists. Contributors include: F.M. Abbott, O. Aginam, T. Amin, L. Biron, A. Denburg, G.E. Evans, J. Harrington, J. Harrison, K. Lee, K.C. Shadlen, P.K. Yu

People who inject drugs (PWID) are at higher risk for acquiring HIV infection than the general population in many countries. Injecting drug use is present in 148 countries including a wide array of low and middle income countries where HIV incidence is growing in recent years - even as it declines elsewhere. This study was undertaken as the third of a series of three economic analyses examining the global epidemics of HIV/AIDS in vulnerable populations. Informed by a critical review of epidemiological evidence and the most recent analyses of intervention efficacy, this work modelled the costs and impact of addressing the needs of PWID at scale in various epidemic contexts. These particular research questions were addressed: What are the modelled epidemic impact and costs of implementing a minimum adaptable package of evidence-based and human rights affirming services for prevention, treatment, and care of HIV/AIDS in PWID in globally representative epidemic scenarios? What are the estimated returns on investment and costs of inaction of addressing these epidemics? Taken together, the findings indicate: Service coverage levels for ART and key harm reduction interventions with HIV prevention benefits are generally inadequate. Allocative decisions for HIV/AIDS should better reflect the burden of transmission and disease. HIV transmission dynamics can be significantly reduced by scaling up a package of four key harm reduction interventions specific to PWID: Needle and Syringe Programs, Medically Assisted Therapy and HIV Counseling and Testing, as well as proportionate access in ART scale-up. Evidence-based and effective interventions for PWID should be funded and implemented - in the context of HIV prevention services for the general population, such as condom promotion. Interventions for PWID - particularly in combination with treatment services - are cost effective or highly cost effective investment choices across the breadth of the global epidemic. The study presents compelling evidence for the most cost-effective approaches to minimising the transmission and impacts of HIV in this key population. This evidence may guide both operational design and policy dialogue in World Bank operations.

This Training Guide was developed to assist Title I HIV planning councils and Title II care consortia in ensuring that all members have the information and skills for full participation in Ryan White Comprehensive AIDS Resources Emergency (CARE) Act planning and implementation activities, with special emphasis on PLWH members . Successful implementation of the CARE Act depends upon the work of planning bodies in communities throughout the nation, and requires that members be diverse, active, and well informed. PLWH involvement in such planning bodies is both a legislative requirement and a practical necessity . The CARE Act, enacted in 1990 and reauthorized in 1996, requires planning councils and consortia to include members from affected communities, including people living with HIV/AIDS (PLWHs). The Division of HIV Services (DHS), which administers Title I and Title II of the CARE Act, believes that effective programs and services must be developed based on the input and perspectives of those for whom the services are intended. The Training Guide was initiated to address the need for orientation and training for planning body members who were people living with HIV disease . A consultant to DHS developed the initial outline. Subsequently, DHS staff and participants in the third Community Discussion Group meeting in October 1995 reviewed, revised, and expanded it. The resulting content outline became the basis for this guide, prepared by MOSAICA: The Center for Nonprofit Development and Pluralism through an interactive process with the PLWH Response Committee of DHS and with John Snow, Inc., the Ryan White Technical Assistance Contractor. Following review of the draft guide, DHS decided that a Training Guide was needed not just for PLWHs but for all planning body members. The guide therefore provides information that can be used for providing orientation and ongoing training to all planning body members, including people living with HIV disease.

Why is there so little HIV education at present directed towards bisexual men and women? This book offers a critical analysis of the issues in public health research and education that prevent adequate attention from being paid to bisexual realities. Addressing the implications of such limited knowledge, the authors raise important questions about the weaknesses of our current response to the HIV/AIDS pandemic. Through interviews with a variety of bisexual men and women, HIV Prevention and Bisexual Realities uncovers innovative, important directions to consider for more effective HIV prevention strategies. The authors' epistemological and methodological assessments of the current state of HIV/AIDS education will be indispensable for community health educators, policy makers, and those who study or work in public health.

On February 23, 2009, a consultation meeting was held to examine the use of peers in HIV interdisciplinary care settings. The meeting was convened by the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), HIVAIDS Bureau (HAB). Participants included HRSA representatives, Ryan White HIV/AIDS Program grantees, researchers, technical assistance providers, health care professionals, program managers and HIV positive peers. Participants heard about the ways in which peers were being used in the fields of HIV, cancer and diabetes to facilitate access to care, treatment and health-related services. The purpose of the meeting, explained Steven Young, HAB's Director of Training and Technical Assistance, was to gain greater insight into the benefits and challenges of having peers on health care teams, to identify the major components of an ideal peer program, and to make recommendations regarding ways in which peer interventions could be funded and sustained within HIV systems of care. Young explained that in the Ryan White HIV/AIDS Program, peers are HIV positive individuals who share identifying characteristics with individuals or population groups receiving care or services. Peers and clients share similar experiences and challenges related to class, race, age, gender, language, culture and recovery from substance abuse and/or trauma. These common characteristics often provide peers with deep insight into the feelings and behaviors of clients, and help them forge both personal credibility and trusting relationship with clients. In the field, said Young, peers are also called coaches, community health workers and patient navigators, among other titles. HAB's particular interest is in examining the role of peers on interdisciplinary health care teams, whose focus in the Ryan White HIV/AIDS Program is to engage and retain clients in high quality, HIV care. Young emphasized the important role that peers (also called consumers) have played in the Ryan White HIV/AIDS Program since its inception. Peers participate in program planning activities, serve as grant reviewers, participate on program advisory committees and boards, and hold positions as volunteers and staff at local health clinics and community-based organizations (CBOs). They serve as faculty of the AIDS Education and Training Centers program. HAB cooperative agreements and grants have supported leadership development for peers to promote their involvement in HIV/AIDS programs. "On an individual level, we have heard from peers that involvement in our programs helps them feel less isolated and gives them an increased sense of purpose," said Young. He added that peers can help improve HIV health care delivery and assessment of client needs, as well as reduce cultural and linguistic barriers, and stigma. Despite widespread acknowledgement within Ryan White that peers play a beneficial role, their function has not been well documented or codified. As a result, HAB is seeking guidance on: Training and support needs of peers; Ideal roles for peers (i.e., staff, volunteers, etc); Financial support for the peer role (grants, reimbursement, etc.); Identification of reasonable client and organizational outcomes related to the use of peers; and Suggestions on how peers might be integrated into specific, legislatively identified core services, such as medical case management and adherence support.

People with HIV/AIDS can live longer, healthier lives because of advances in treatment of HIV infection. However, longer lives are associated with increased prevalence of 1) adverse effects of HIV infection, 2) adverse effects of the drugs used to treat HIV, and 3) concurrent medical conditions that would occur in the absence of HIV. These long-term complications have put HIV infection in the realm of chronic diseases rather than of infectious diseases, which usually respond to short-term clinical interventions. Effective management of chronic diseases in the primary care setting requires the coordination of interventions that occur at the level of the clinical services, the community supports for those clinical services, and the individual patient. While clinical services begin in the primary care clinic, community supports are needed, and the patient must be engaged to enhance self-management. The coordinated interventions together contribute to the desired clinical outcomes. The Chronic Care Model, which is used in the design and quality improvement activities of clinical services, conceptualizes how these factors impact the clinical outcome of chronic disease management. This book addresses several important aspects of HIV/AIDS care and treatment in a concise, accessible format; it is not meant to be a comprehensive reference book. Recommended references and citations are provided for the reader to be able to access in-depth information on topics that are particularly important and/or controversial. Appropriate use of antiretroviral drugs, treatment of opportunistic infections, symptom management, treatment of concurrent medical conditions, and other specific interventions to treat HIV disease and its complications are addressed. The format of this guide is designed to provide practical information for the common questions that arise in the care of patients with HIV infection. Recognizing the broader array of best practices that contribute to effective clinical outcomes among patients with a complex array of service needs, the authors also address patient evaluation, adherence, mental health, substance abuse, overall clinic management, and other factors that lead to improved patient outcomes according to the Chronic Care Model. Last, because the authors recognize the challenges of maintaining clinical practices in the face of rapidly changing and ever more complex treatment interventions, a chapter on sources for updated and in-depth clinical information is provided. Pediatric HIV/AIDS treatment is not addressed in this book.

"Making a Difference " has been developed to help community members to become involved in local decision making that will determine what HIV services are available in their community. While this Consumer Digest may be helpful to many types of community members, its primary purpose is to support persons living with HIV disease to be effective participants on Ryan White planning bodies. Whether you already are involved in your planning body process or wish to learn more before Making the Commitment to get involved, Making a Difference can help you. The CARE Act (Comprehensive AIDS Resources Emergency) is the Federal law that provides money to cities, States, community-based organizations and other types of organizations to provide HIV services. The CARE Act specifically requires that HIV services planning bodies include persons living with HIV disease. These Title I planning councils and Title II planning bodies and consortia (collectively referred to as Ryan White planning bodies throughout this document) have a big impact on determining the types of HIV services - and which specific programs - are available in a community. In recent years, Congress has appropriated (or designated) funding in the range of $2 billion per year to support HIV health services through the CARE Act. Much of this money is distributed to States and local governments that rely on planning bodies to help them identify who is affected by the HIV epidemic, set priorities for the types of HIV services that are needed, and determine how best to allocate funding among multiple priorities. Persons living with HIV disease (PLWH) are critical to the success of these planning processes because they bring a perspective that is different from other members and know firsthand what services are needed. They also can help make sure that different groups of PLWH are included in the process and that their service needs are not overlooked. The Health Resources and Services Administration's (HRSA) HIV/AIDS Bureau (HAB) is the Federal agency responsible for administering the CARE Act. HAB produced this Consumer Digest with the assistance of PLWH members of planning bodies and PLWH trainers at national HIV/AIDS organizations. This document provides new information regarding the CARE Act Amendments of 2000 related to PLWH involvement, and draws upon other publications and materials useful to PLWH on (or considering serving on) a planning body. This digest is intended to provide you with information and tools to help you Make a Difference by serving your community as an active and informed member of a Ryan White planning body.

The Ryan White HIV/AIDS Program was borne of a movement that began with the onset of the AIDS epidemic in America. First by the tens, then by the hundreds, then by the thousands, brave and commit-ted people from all walks of life made a decision to get involved. Some were public health officials; others were activists. Some were community leaders, and others-at least until that time-were citizens quietly living their lives. In this sixth edition of the U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) Progress Report, we celebrate the legacy of those first responders. We also celebrate the incredible journey we have taken since 1990, when the first Ryan White Comprehensive AIDS Resources Emergency (CARE) Act was passed into law. Who could have imagined in those early years that we would one day have treatments powerful enough to forestall the progression of HIV/AIDS? Who could have known that we would touch so many lives? This year alone, through scores of grantees and providers* in cities and towns across America, the Ryan White HIV/ AIDS Program will serve well over half a million people. We continue to face hurdles in our fight against the epidemic, but we have made enormous progress. Highlights from this year include the following: At $2.29 billion, FY 2010 appropriations for the Program were the largest in Program history; Our AIDS Education and Training Centers (AETCs) conducted more than 18,000 trainings; Under the AIDS Drug Assistance Program (ADAP), we distributed medications to more than 175,000 clients; We treated the people most disproportionately affected by HIV: 73 percent of our clients were racial and ethnic minorities, and 88 percent of our clients had no private health insurance; We conducted research on innovative, replicable models of HIV care to reduce health disparities in women of color, improve access to oral health care, establish linkages between jail settings and HIV primary care, and expand health information technology and electronic medical systems; We have been involved in the Healthy People 2010 broad-based national collaborative to meet the Nation's most pressing health needs; We continue to set the standard for HIV/AIDS care using well-respected performance measures. This response to HIV/AIDS constitutes nothing less than a modern public health miracle. . . and within it lie other miracles, too-like that of an HIV-positive person living into old age, or the promising future that unfolds before the eyes of an HIV-positive adolescent. In this publication, you will read about many of the milestones we have encountered in our 20-year journey and the many qualities that make our team successful. We embarked on a quest that many would not. We stepped up to the plate when others stepped away. And today we constitute a powerful and cohesive force seldom seen in combating a single disease. Our rewards lie in victory after victory over isolation and disease and in the improved lives of our clients. It has been an amazing and empowering journey, and it is not over. We are trained. We are committed. We are full of resolve. And we will not stop. In this Progress Report, we remember and we honor the determination of those first responders and of Ryan White himself. It was the determination to go the distance for people living with HIV/AIDS, what-ever it took and whatever the cost. That determination has never been more alive than it is today.

This document is to help the CARE Act1 community conduct needs assessments so that they can better plan on how to use CARE Act resources to fill gaps in care. It describes the process of needs assessment and provides "how-to" information about tasks ranging from developing an epidemiologic profile to estimating the need for services. The Guide provides: Legislative requirements and HIV/AIDS Bureau (HAB) expectations for each CARE Act title; Types of needs assessment information; Steps in conducting a comprehensive needs assessment; Practical guidance on how to: Prepare an epidemiologic profile; Collect and use surrogate markers for HIV/AIDS, such as co-morbidity data; Collect information from people living with HIV disease (PLWH) and other community representatives through focus groups, surveys, interviews, and community forums; Prepare a resource inventory; Conduct an assessment of provider capacity/capability, and Assess service needs. Ways to use needs assessment results in decision making; The experiences of CARE Act Titles I, II, III, and IV grantees nationwide, and; Information on special HAB needs assessment initiatives (i.e., preparing a joint epidemiologic profile with an HIV prevention community planning body, developing a framework for estimating unmet need). The Needs Assessment Guide was designed for use by all CARE Act titles and can provide a common approach to needs assessment that facilitates cross-title collaboration. Input on its content was provided by HAB staff and a Field Review Group. Title I and Title II needs assessments typically involve planning bodies-Title I HIV services planning councils and Title II regional consortia or Statewide planning entities. Therefore, the roles of planning bodies are described throughout. For Title III or Title IV, the planning body may be an agency's planning committee or executive committee. Many programs also establish advisory bodies that include community and PLWH participation-or there may be no planning body involvement.

This document is provided as an information resource for physicians and other health care professionals to guide them in the appropriate treatment of patients with HIV/AIDS. Recommendations for care and treatment change rapidly, and opinions can be controversial; therefore, physicians and other health care professionals are encouraged to consult other sources, especially manufacturers' package inserts, and confirm the information contained in these tables. The individual physician or other health care professional should use his/her best medical judgment in determining appropriate patient care or treatment because no single reference or service can take the place of medical training, education, and experience. Determination of appropriate treatment is the responsibility of the treating physician

There are various reasons for taking an interest in the treatment for HIV/AIDS. Unfortunately, AIDS has no cure at the moment. But in the absence of a cure, medical science resorts to available treatment options. In seven chapters, this handy book has been designed to help people seek information about treatment strategies for HIV/AIDS. These include: a general introduction to HIV/AIDS antiretroviral therapy (ART) dynamics of ARV drugs merits and demerits of ARV drugs revival of immune systems in HIV infection foundations of immunosuppression hints for the HIV-positive. The book also includes details of websites for further research, review questions for those preparing for coursework or examinations, a glossary of terms and an index. By explaining a complex disease as one that can be understood and managed, HIV/AIDS Treatment Strategies provides clear and useful information about this important subject area. S D Browne-Umar was born on 16 July 1947 in Axim, Ghana. He worked in Ghana and Nigeria as a science educationist prior to being engaged by UNICEF in north-west Nigeria. He was a consultant field investigator for the Ghana AIDS Commission. Currently, Browne-Umar consults on global HIV education and vaccinology.

Compelled by his own 2005 HIV diagnosis, journalist John-Manuel Andriote revisits his acclaimed chronicle of the AIDS epidemic in this updated and expanded edition of the University of Chicago Press 1999 hardcover original. Andriote examines the impact of AIDS on individuals and on the gay civil rights movement, from the coming-out revelry of the 1970s to the post-AIDS gay community of the twenty-first century's first decade. Victory Deferred looks at how AIDS has changed both individual lives and national organizations. It tells the story of how a health crisis pushed a disjointed jumble of local activists to become a national visible and politically powerful civil rights movement, a full-fledged minority group challenging the authority of some of the nation's most powerful institutions. Based on hundreds of interviews with those at the forefront of the medical, political, cultural, civic, and national responses to the epidemic, Victory Deferred artfully blends personal narratives with institutional histories and organizational politics to show how AIDS forced gay men from their closets and ghettos into the hallways of power to lobby and into the streets to protest.

Journeys Through Darkness is a biography which tells the story of AIDS and related blindness through AIDS warrior and long-term survivor, award-winning legally blind photographer Kurt Weston. The book includes several of his photographs that match the powerful prose of Alina Oswald.

The Invisible People is a revealing and at times shocking look inside the United States's response to one of the greatest catastrophes the world has ever known -- the global AIDS crisis. A true story of politics, bureaucracy, disease, internecine warfare, and negligence, it illustrates that while the pandemic constitutes a profound threat to U.S. economic and security interests, at every turn the United States has failed to act in the face of this pernicious menace. During the past twenty years, more than 65 million people across the globe have become infected with HIV. Already 25 million around the world have died -- more than all of the battle deaths in the twentieth century combined. By decade's end there will be an estimated 25 million AIDS orphans. If trends continue, by 2025, 250 million global HIV-AIDS cases are a distinct possibility. Beyond the ineffable human toll, the pandemic is reshaping the social, economic, and geopolitical dimensions of our world. Eviscerating national economies, creating an entire generation of orphans, and destroying military capacity, the disease is generating pressures that will lead to instability and possibly even state failure and collapse in sub-Saharan Africa. Poised to explode in Eastern Europe, Russia, India, and China, AIDS will have devastating and destabilizing effects of untold proportions that will reverberate throughout the global economy and the international political order. In this gripping account that draws on more than two hundred interviews with key political insiders, policy makers, and thinkers, Greg Behrman chronicles the red tape, colossal blunders, monumental egos, power plays, and human pain and suffering that comprise America's woeful response to the AIDS crisis. Behrman's unprecedented access takes you inside the halls of power from seminal White House meetings to tumultuous turf battles at World Health Organization headquarters in Geneva, heated debates in the United Nations, and chilling discoveries at the Centers for Disease Control. Behrman also brings us into the field to meet the people who live in the midst of AIDS devastation in places like a school yard in Namibia, the red-light district in Bombay, and an orphanage in South Africa. Intensely researched and vividly detailed, The Invisible People is a groundbreaking and compellingly readable account of the appalling destruction caused by more than two decades of American abdication in the face of the defining humanitarian catastrophe of our time.

Journeys Through Darkness is a biography which tells the story of AIDS and related blindness through AIDS warrior and long-term survivor, award-winning legally blind photographer Kurt Weston. The book includes several of his photographs that match the powerful prose of Alina Oswald.

With improvements in the treatment of HIV disease, gay men in great numbers are surviving--and thriving--into middle and older age. While increased longevity brings new hope, it also raises unanticipated challenges, particularly for gay men who never thought they would live this long: How do I deal with all the physical changes? Who can I rely on as I get older? Is a relationship still in the cards for me? What about sex? How should I prepare for old age?
A one-of-a-kind guide for gay men aging with HIV, Aging with HIV offers an upbeat, down-to-earth approach for adapting to change, whether driven by age, AIDS, or both. Psychotherapist James Masten and physician James Schmidtberger shed light on the many common assumptions and fears of aging with HIV. Aging with HIV provides concrete solutions for facing midlife with a positive outlook, offering a wealth of advice for breaking unhealthy habits and coping mechanisms. The book describes the nine changes common to gay men as they age with HIV, discusses the four challenges of aging, and offers a unique ten-step path to optimal aging with HIV, helping the reader to tailor the book's suggestions to the realities of their lives. Woven throughout the book are first-person narratives from men who recount what worked--and did not work--for them. In addition, Rapid Research, Fast Fact, and Self-Reflection boxes highlight the latest research and challenge readers to take stock of the present--and plan for the future.
An invaluable tool to keep handy and to refer to often, Aging with HIV is an inviting, confident companion to navigating midlife and beyond with HIV.

Although overall HIV prevalence in South Asia is low, the widespread stigma attached to HIV and AIDS impedes efforts to reach people most in need of prevention, care, and treatment services. To address this challenge, the 2008 South Asia Region Development Marketplace partnership, led by the World Bank, launched a competitive grants program to support innovative community approaches. 'Tackling HIV-Related Stigma and Discrimination in South Asia' summarizes the monitoring, evaluation, and case study data and documents successful community innovations. Twenty-six community groups in Afghanistan, Bangladesh, India, Nepal, Pakistan, and Sri Lanka received funds. The initiatives involved a broad spectrum, including vulnerable groups as well as people living with HIV, the media, local government authorities, health workers, and religious leaders. The interventions used traditional cultural and media approaches to discuss taboo subjects. The reach of the initiatives was amplifi ed by involving opinion leaders. The strategies engaged marginalized groups to design and lead the interventions and to facilitate contact between groups experiencing stigma and the general public to reduce fears and misconceptions about transmission. Projects that combined economic and stigma reduction interventions helped the marginalized populations to overcome the internalized stigma and become empowered to advocate for their rights. 'Tackling HIV-Related Stigma and Discrimination in South Asia' identifies effective strategies to raise awareness and reports on shifts--albeit slow--of attitudes, norms, and behaviors. Through its recommendations for successful interventions to reduce barriers to effective HIV prevention, care, and treatment programs, the book provides a strong foundation on which to build stigma reduction efforts in the region and world.